PMC:7784786 / 146-254 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":85,"end":95},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:C000597346"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"mmatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclo"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":8,"end":33},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"mmatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclo"}